Plasma Technology
Poster presentation at the International Symposium on the Diabetic Foot Conference, Hague.
Wednesday 22nd May 2019
A great poster presentation from Dr Aye Aye Thant at the ISDF 2019 conference!
Dr Thant’s presentation demonstrated the benefits of using the Adtec SteriPlas on diabetic foot ulcer patients.
Prior to the use of the Adtec SteriPlas, all patients in their retrospective study suffered from chronic and non-healing foot and leg ulcers with multi resistant bacteria and recalcitrance to antibiotics. All patients had at least 3 courses of intravenous antibiotics for more than 6 weeks prior with poor response.
The Adtec SteriPlas was then introduced as a treatment option. Instantly, positive results could be seen with the infection management for these patients. For example, one patient who was previously considered for an amputation was now improved and risk free. Healthy granulation could be observed with all patients, offering hope and an alternative to antibiotics that would usually be offered.
For more information on the Adtec SteriPlas, visit our website www.adtecplasma.com or send us an email at info@adtec.eu.com
Mr Keith Cutting presents significant results on DFUs in Vienna conference
Mr Keith Cutting presented at The European Conference on Controversies in Diabetic Foot Management conference in Vienna last week. His presentation focused on the benefits of treating complex diabetic foot ulcer patients with the Adtec SteriPlas.
The Adtec SteriPlas has shown promising results leading to healing in problematic and non-healing wounds such as diabetic foot ulcers or surgical site infections. These complex wounds that have shown signs of stalled healing respond well to intervention with the Adtec SteriPlas.
To learn more about our medical device and the benefits it offers to patients with wounds, surgical site infections and dermatological conditions send us an email at info@adtec.eu.com
Deutscher Wundkongress, Bremen 2019
Adtec Healthcare is excited to participate at the DEWU Deutscher Wundkongress in collaboration with other plasma medicine companies next week in Bremen.
https://www.bremer-pflegekongress.de/Teilnehmer_allgemeine_Informationen_w
The plasma medicine companies will introduce the different plasma technologies, product and clinical safety and introduce some of the clinical evidence gathered so far.
This is an exciting opportunity to learn more about gas plasma and we encourage you to attend the session to see the benefits of gas plasma in clinic practice.
Adtec SteriPlas featured in conference presentations for 2019
Adtec Healthcare is excited to attend and support the clinicians presenting at the following conferences for 2019:
The European Conference on Controversies in Diabetic Foot Management conference in Vienna, 2nd – 3rd May 2019 (https://www.diabeticfoot-europe.com/).
Mr Keith Cutting will be conducting an oral presentation on Friday 3rd May at 14:00. His presentation is titled, “Interim Results from Currently Running Study on the Treatment of Biofilm Infection in Diabetic Foot Ulcers Using Gas Plasma”.
The ISDF 2019 conference in The Netherlands, 22nd – 25th May 2019 (https://diabeticfoot.nl/).
Dr Aye Aye Thant from Kettering General Hospital NHS Foundation Trust will be conducting a poster presentation on “Adtec Cold Plasma Treatment to Assist in Treating Diabetic Foot with Multi Resistant Infection”. This will be presented on Wednesday 22nd May from 12:10.
The European Wound Management Association (EWMA) conference in Gothenburg, Sweden, 5th – 7th June 2019 (https://ewma.org/ewma-conference/2019/). Presenting clinical evidence at this conference will be:
Maurice Moelleken from the Universitätsklinikum Essen, Germany. Maurice’s oral presentation on “Prospective RCT to validate the interval of cold atmospheric plasma treatment for reduction of bacterial load, wound area and pain in patients with chronic wounds” will be presented on 6th June at 08:50am.
Dr Michael Pierides from Kettering General Hospital NHS Foundation Trust will have an e-poster at the EWMA conference. His poster, “The Gas Plasma Medical Device: A Novel Therapy in Treating Non-Resolving Infected Diabetic Foot and Leg Ulcers” can be viewed throughout the conference.
Dr Heinrich Rotering from the Universitätsklinikum Münster, Germany will be conducting a poster presentation, “Cold Plasma and Advanced Negative Pressure Wound Treatment – Long Term Follow Up of Treated Infected Implants in Cardiac Surgery”, on 6th June between 09:42 – 09:45.
The Surgical Infection Society Europe conference in Dublin, Ireland, 26th – 28th June (http://sis-e.org/2019/).
Dr Heinrich Rotering will have a poster at this conference. His poster, “Infection of Cardiovascular Implantable Electronic Devices (CIED) – New Approach with Cold Atmospheric Plasma (CAP)” can be viewed throughout the conference.
Adtec Healthcare staff will be present at these conferences to support the presenting speakers and welcome any meetings. Please get in contact with us at info@adtec.eu.com to secure your meeting in advance.
Gas plasma shows promising results in the treatment of non-healing wounds
Renowned for its ability to successfully treat non-healing wounds, the Adtec SteriPlas is a must have for any dermatology and wound care departments.
This 61-year-old patient with a long-term venous ulcer was stalled from healing and present with Klebsiella oxytoca and Enterobacter cloacae. The patient went through a short treatment programme with our gas plasma medical device to achieve exceptional results. Figures (a) - (b) shows the visual changes of the ulcer throughout the short course of treatment with the Adtec SteriPlas.
At the end of the treatment programme, swabs which would normally have shown signs of bacteria were now sterile, allowing the patient to further progress into full healing.
Interested to hear more? Reach out to us at info@adtec.eu.com
Surgical site infections treated with the Adtec SteriPlas
Surgical site infections (SSIs) are still a severe complication after cardiac surgery with a mortality estimated range of up to 40% of cases. These post-operative wounds are generally associated with longer hospital stay and the delayed or inadequate therapeutic measures can lead to avoidable hospital costs for the healthcare system. The significant cost burden on the hospital for a single SSI case is €36,000. 1
It has already been shown that the Adtec SteriPlas is effective due to its increased penetration depth in SSIs to defeat bacteria even under a layer of biofilm independently to their resistance profile. This includes multi-resistant bacteria that have shown little or no response to antibiotics previously. In combination with advanced negative pressure wound treatment (aNPWT), the Adtec SteriPlas has been praised as a “tissue saving approach” offering patients a favourable treatment method for these complicated and chronic wounds compared to conventional treatment therapies. 2
Studies conducted using the Adtec SteriPlas have shown a significant decrease in the mortality rate coupled with accelerated healing. Patients with infected drivelines such as those with left ventricular assist devices have healed in as quick as 1 week, and patients with sternal SSIs have healed in as quick as 6 days. 2,3
Both patients and doctors have praised the Adtec SteriPlas for its exceptional ability at delivering promising results leading to healing.
Be sure to contact us for more information and to see how our medical device may benefit your patients.
- H. Rotering, Cold atmospheric plasma – New options for infection control in wound management, EWMA 2016.
- H. Rotering, Cold atmospheric plasma and advanced Negative Pressure Wound Treatment – First results of a tissue saving approach for deep surgical site infections, EACTS 2018.
- H. Rotering, Das infizierte Implantat, Komplexe Wundbehandlung – Kaltes atmospherisches Plasma und advanced NPWT in der Herzchirurgie, Chirurgie 2019.
Promising results for the treatment of diabetic foot ulcers using the Adtec SteriPlas
We are excited to show you a recent conference poster presented at the BSAC Spring 2019 conference, submitted by Kettering General Hospital NHS Foundation Trust.
The poster shows the promising results of the using the Adtec SteriPlas on diabetic foot ulcers that are stalled by biofilm. The SteriPlas “is postulated as an alternative for antibiotics for patients where antibiotic therapy is difficult (due to resistance or adverse effects) or as an adjunct treatment for patients with chronic wounds including those with biofilms”.
Contact us at info@adtec.eu.com to learn more about how the Adtec SteriPlas may benefit your non-healing wound patients.
Innovation Award for SteriPlas Plasma Technology.
Adtec Healthcare congratulates Dr Rotering on his receipt of the runner up Innovation award at the European Association for Cardio-Thoracic Surgery (EACTS) conference in Vienna on October 7th 2017..
Adtec receives second place award in the ‘Most Innovative Product’ Category in Journal of Wound Care awards
We are delighted to be awarded second place in the ‘Most Innovative Product:’ category at the Journal of Wound Care/ World Union of Wound Healing Societies awards. The results were announced at the awards ceremony on Tuesday September 27th during the WUWHS congress in Florence.
Clinical Trial to investigate the potential benefits of treating Actinic Keratosis with Adtec SteriPlas plasma technology.
Adtec Europe today announces the launch of a clinical trial to evaluate the change of the cutaneous microbiome in correlation to the efficacy of SteriPlas plasma technology compared to standard treatments on patients with Actinic Keratosis.